Renovaro BioSciences retains American Defense International

Lunai Bioworks has retained American Defense International, a Washington, D.C.-based consulting and government affairs firm specializing in defense and national security. This collaboration is designed to support U.S. government agencies in the development of advanced countermeasures against chemical and biological weapons, including highly toxic agents such as sarin nerve gas. Lunai and ADI will work together to position Lunai’s proprietary AI-enabled biomedical data platforms as key assets in identifying, testing, and accelerating the development of protective and therapeutic responses to emerging national security threats.